001     303954
005     20250821114622.0
024 7 _ |a 10.1093/jncimonographs/lgaf007
|2 doi
024 7 _ |a pmid:40828157
|2 pmid
024 7 _ |a 1052-6773
|2 ISSN
024 7 _ |a 1745-6614
|2 ISSN
037 _ _ |a DKFZ-2025-01729
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schmitz, Kathryn H
|0 0000-0003-2400-2935
|b 0
245 _ _ |a Exercise oncology comes of age.
260 _ _ |a Oxford
|c 2025
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1755758240_3177
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Exercise oncology is coming of age, with more than 30 000 peer-reviewed citations in the scientific literature and multiple guidelines published by major medical institutions based on strong evidence from randomized controlled trials. There is enthusiasm around the formation of a new international organization that will form a nexus for exercise oncology researchers, clinicians, and practitioners. The contents of this monograph document the progression of exercise oncology research and practice, laying the groundwork for the formation of the International Society of Exercise Oncology. The society will aim to be an organizing body to shepherd the field toward the goal of using exercise as standard of care in the setting of oncology in collaboration with existing medical organizations so that every patient can benefit.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Wiskemann, Joachim
|0 P:(DE-He78)60b584aeef81e4c57fd111fa63779b73
|b 1
|u dkfz
700 1 _ |a May, Anne M
|b 2
773 _ _ |a 10.1093/jncimonographs/lgaf007
|g Vol. 2025, no. 71, p. 301 - 303
|0 PERI:(DE-600)2044141-1
|n 71
|p 301 - 303
|t Journal of the National Cancer Institute / Monographs
|v 2025
|y 2025
|x 1052-6773
909 C O |o oai:inrepo02.dkfz.de:303954
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)60b584aeef81e4c57fd111fa63779b73
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2025
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-12
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-12
920 1 _ |0 I:(DE-He78)D120-20160331
|k D120
|l Angewandte Tumor-Immunität
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D120-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21